|
DSG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.172000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.923900E-02 |
| Normal-vs-Stage2 |
7.265800E-01 |
| Normal-vs-Stage3 |
2.330000E-02 |
| Normal-vs-Stage4 |
2.169900E-02 |
| Stage1-vs-Stage2 |
1.096360E-01 |
| Stage1-vs-Stage3 |
3.325000E-01 |
| Stage1-vs-Stage4 |
2.567000E-01 |
| Stage2-vs-Stage3 |
5.105800E-02 |
| Stage2-vs-Stage4 |
3.349600E-02 |
| Stage3-vs-Stage4 |
7.534400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.166340E-02 |
| Normal-vs-AfricanAmerican |
2.341600E-01 |
| Normal-vs-Asian |
5.816400E-02 |
| Caucasian-vs-AfricanAmerican |
9.384600E-01 |
| Caucasian-vs-Asian |
6.261400E-01 |
| AfricanAmerican-vs-Asian |
8.110800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.018600E-01 |
| Normal-vs-Female |
3.778100E-03 |
| Male-vs-Female |
3.482600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.854370E-02 |
| Normal-vs-Age(41-60Yrs) |
9.580500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.494420E-01 |
| Normal-vs-Age(81-100Yrs) |
7.809600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.554000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.392200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.435400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.166200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.068000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.054000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.772110E-02 |
| Classical-VS-Follicular |
1.59350310724449E-11 |
| Classical-VS-Other |
4.208800E-01 |
| Classical-VS-Normal |
6.439500E-04 |
| Tall-VS-Follicular |
8.86629999974353E-07 |
| Tall-VS-Other |
7.808200E-02 |
| Tall-VS-Normal |
3.387900E-04 |
| Follicular-VS-Other |
1.679210E-01 |
| Follicular-VS-Normal |
8.958800E-03 |
| Other-VS-Normal |
7.926200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.339600E-01 |
| Normal-vs-N1 |
1.039560E-01 |
| N0-vs-N1 |
1.142450E-01 |
|
|
